AbstractHypertrophic cardiomyopathy is a complex cardiac disease with unique pathophysiological characteristics and a great diversity of morphological, functional, and clinical features. Two thirds of patients with HCM display evidence of obstruction in the left ventricular outflow tract. This review describes current management of patients with HCM with a special focus on interventional therapy using alcohol septal ablation
Percutaneous alcohol septal ablation (ASA) is an effective and minimally invasive therapeutic strate...
Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a heterogeneous disease with different...
Percutaneous alcohol septal ablation (ASA) is an effective and minimally invasive therapeutic strate...
AbstractHypertrophic cardiomyopathy is a complex cardiac disease with unique pathophysiological char...
Alcohol septal ablation is a minimally invasive, safe, and effective procedure for the treatment of ...
Hypertrophic cardiomyopathy (HCM) is a highly heterogeneous disease with varied patterns of hypertro...
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited condition defined by left ventr...
International audienceOutcomes of septal alcoholization in hypertrophic obstructive cardiomyopathy a...
International audienceHypertrophic obstructive cardiomyopathy (HOCM) is the most frequent genetic ca...
Hypertrophic cardiomyopathy is the most common genetic cardiovascular disorder and is associated wit...
Hypertrophic obstructive cardiomyopathy (HOCM) is characterized by inappropriate myocardial hypertro...
Hypertrophic obstructive cardiomyopathy (HOCM) is the most frequent genetic cardiovascular affection...
Obstruction in hypertrophic cardiomyopathy is associated with increased morbidity and mortality. Eff...
Percutaneous alcohol septal ablation (ASA) is an effective and minimally invasive therapeutic strate...
Background: Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart disease with a var...
Percutaneous alcohol septal ablation (ASA) is an effective and minimally invasive therapeutic strate...
Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a heterogeneous disease with different...
Percutaneous alcohol septal ablation (ASA) is an effective and minimally invasive therapeutic strate...
AbstractHypertrophic cardiomyopathy is a complex cardiac disease with unique pathophysiological char...
Alcohol septal ablation is a minimally invasive, safe, and effective procedure for the treatment of ...
Hypertrophic cardiomyopathy (HCM) is a highly heterogeneous disease with varied patterns of hypertro...
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited condition defined by left ventr...
International audienceOutcomes of septal alcoholization in hypertrophic obstructive cardiomyopathy a...
International audienceHypertrophic obstructive cardiomyopathy (HOCM) is the most frequent genetic ca...
Hypertrophic cardiomyopathy is the most common genetic cardiovascular disorder and is associated wit...
Hypertrophic obstructive cardiomyopathy (HOCM) is characterized by inappropriate myocardial hypertro...
Hypertrophic obstructive cardiomyopathy (HOCM) is the most frequent genetic cardiovascular affection...
Obstruction in hypertrophic cardiomyopathy is associated with increased morbidity and mortality. Eff...
Percutaneous alcohol septal ablation (ASA) is an effective and minimally invasive therapeutic strate...
Background: Hypertrophic cardiomyopathy (HCM) is the most common hereditary heart disease with a var...
Percutaneous alcohol septal ablation (ASA) is an effective and minimally invasive therapeutic strate...
Background: Hypertrophic obstructive cardiomyopathy (HOCM) is a heterogeneous disease with different...
Percutaneous alcohol septal ablation (ASA) is an effective and minimally invasive therapeutic strate...